Zoetis Research Development vs Total Operating Expenses Analysis

ZTS Stock

USD 176.96 0.25 0.14%

Zoetis financial indicator trend analysis is more than just analyzing Zoetis Inc current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zoetis Inc is a good investment. Please check the relationship between Zoetis Research Development and its Total Operating Expenses accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Research Development vs Total Operating Expenses

Research Development vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zoetis Inc Research Development account and Total Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Zoetis' Research Development and Total Operating Expenses is 0.91. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Zoetis Inc, assuming nothing else is changed. The correlation between historical values of Zoetis' Research Development and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Zoetis Inc are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Research Development i.e., Zoetis' Research Development and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most indicators from Zoetis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zoetis Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Sales General And Administrative To Revenue is likely to gain to 0.30 in 2024, whereas Selling General Administrative is likely to drop slightly above 1.3 B in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	224M	221M	239M	159.1M
Depreciation And Amortization	448M	465M	491M	515.6M

Interest Expense Depreciation And Amortization

Zoetis fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		-0.39	-0.25	-0.33	-0.29	-0.41	-0.22	-0.43	0.32	-0.18	-0.2	-0.29	-0.41	-0.41	-0.31	-0.23	-0.29	-0.4	-0.37	-0.25	-0.37	-0.43	0.63	-0.27	-0.78	-0.35
Total Assets	-0.39		0.9	0.68	0.82	0.56	0.76	0.94	-0.07	0.73	0.6	0.94	0.98	0.49	0.58	0.87	0.94	0.78	0.97	0.88	0.85	0.96	-0.86	0.92	0.75	0.98
Short Long Term Debt Total	-0.25	0.9		0.49	0.78	0.15	0.82	0.77	0.08	0.93	0.57	0.88	0.87	0.22	0.26	0.99	0.89	0.75	0.9	0.99	0.72	0.8	-0.86	1.0	0.57	0.89
Other Current Liab	-0.33	0.68	0.49		0.45	0.62	0.38	0.7	-0.63	0.31	0.51	0.62	0.65	0.61	0.63	0.5	0.62	0.55	0.61	0.5	0.71	0.73	-0.56	0.51	0.63	0.69
Total Current Liabilities	-0.29	0.82	0.78	0.45		0.4	0.44	0.78	0.11	0.61	0.62	0.83	0.75	0.28	0.52	0.68	0.83	0.7	0.74	0.68	0.77	0.72	-0.72	0.79	0.64	0.87
Total Stockholder Equity	-0.41	0.56	0.15	0.62	0.4		0.16	0.69	-0.33	-0.11	0.23	0.46	0.58	0.73	0.81	0.1	0.45	0.32	0.51	0.13	0.56	0.65	-0.31	0.19	0.62	0.52
Other Liab	-0.22	0.76	0.82	0.38	0.44	0.16		0.55	0.1	0.76	0.24	0.72	0.8	0.12	0.19	0.84	0.73	0.43	0.85	0.86	0.43	0.65	-0.62	0.82	0.34	0.67
Property Plant And Equipment Net	-0.43	0.94	0.77	0.7	0.78	0.69	0.55		-0.17	0.6	0.58	0.81	0.92	0.7	0.67	0.73	0.81	0.83	0.87	0.74	0.93	0.97	-0.84	0.79	0.83	0.91
Current Deferred Revenue	0.32	-0.07	0.08	-0.63	0.11	-0.33	0.1	-0.17		0.09	0.01	0.05	-0.09	-0.47	-0.09	0.04	0.05	-0.21	-0.04	0.05	-0.29	-0.14	0.17	0.07	-0.4	-0.06
Net Debt	-0.18	0.73	0.93	0.31	0.61	-0.11	0.76	0.6	0.09		0.43	0.64	0.73	0.17	0.03	0.94	0.65	0.71	0.76	0.93	0.61	0.63	-0.81	0.91	0.43	0.68
Accounts Payable	-0.2	0.6	0.57	0.51	0.62	0.23	0.24	0.58	0.01	0.43		0.62	0.5	0.16	0.4	0.56	0.62	0.75	0.49	0.56	0.57	0.62	-0.57	0.6	0.49	0.67
Cash	-0.29	0.94	0.88	0.62	0.83	0.46	0.72	0.81	0.05	0.64	0.62		0.86	0.23	0.5	0.84	1.0	0.65	0.88	0.85	0.71	0.85	-0.75	0.89	0.61	0.97
Non Current Assets Total	-0.41	0.98	0.87	0.65	0.75	0.58	0.8	0.92	-0.09	0.73	0.5	0.86		0.55	0.56	0.85	0.87	0.74	0.99	0.86	0.8	0.95	-0.83	0.89	0.72	0.91
Non Currrent Assets Other	-0.41	0.49	0.22	0.61	0.28	0.73	0.12	0.7	-0.47	0.17	0.16	0.23	0.55		0.68	0.21	0.23	0.51	0.45	0.22	0.68	0.61	-0.48	0.24	0.65	0.4
Other Assets	-0.31	0.58	0.26	0.63	0.52	0.81	0.19	0.67	-0.09	0.03	0.4	0.5	0.56	0.68		0.2	0.5	0.35	0.49	0.22	0.61	0.64	-0.35	0.3	0.51	0.56
Long Term Debt	-0.23	0.87	0.99	0.5	0.68	0.1	0.84	0.73	0.04	0.94	0.56	0.84	0.85	0.21	0.2		0.85	0.75	0.88	1.0	0.69	0.79	-0.86	0.99	0.54	0.86
Cash And Short Term Investments	-0.29	0.94	0.89	0.62	0.83	0.45	0.73	0.81	0.05	0.65	0.62	1.0	0.87	0.23	0.5	0.85		0.65	0.89	0.86	0.71	0.85	-0.75	0.9	0.61	0.97
Net Receivables	-0.4	0.78	0.75	0.55	0.7	0.32	0.43	0.83	-0.21	0.71	0.75	0.65	0.74	0.51	0.35	0.75	0.65		0.7	0.74	0.84	0.8	-0.87	0.77	0.78	0.79
Good Will	-0.37	0.97	0.9	0.61	0.74	0.51	0.85	0.87	-0.04	0.76	0.49	0.88	0.99	0.45	0.49	0.88	0.89	0.7		0.9	0.75	0.92	-0.81	0.91	0.66	0.9
Non Current Liabilities Total	-0.25	0.88	0.99	0.5	0.68	0.13	0.86	0.74	0.05	0.93	0.56	0.85	0.86	0.22	0.22	1.0	0.86	0.74	0.9		0.69	0.8	-0.85	0.99	0.54	0.86
Inventory	-0.37	0.85	0.72	0.71	0.77	0.56	0.43	0.93	-0.29	0.61	0.57	0.71	0.8	0.68	0.61	0.69	0.71	0.84	0.75	0.69		0.87	-0.84	0.74	0.84	0.86
Other Current Assets	-0.43	0.96	0.8	0.73	0.72	0.65	0.65	0.97	-0.14	0.63	0.62	0.85	0.95	0.61	0.64	0.79	0.85	0.8	0.92	0.8	0.87		-0.84	0.83	0.8	0.92
Other Stockholder Equity	0.63	-0.86	-0.86	-0.56	-0.72	-0.31	-0.62	-0.84	0.17	-0.81	-0.57	-0.75	-0.83	-0.48	-0.35	-0.86	-0.75	-0.87	-0.81	-0.85	-0.84	-0.84		-0.87	-0.87	-0.84
Total Liab	-0.27	0.92	1.0	0.51	0.79	0.19	0.82	0.79	0.07	0.91	0.6	0.89	0.89	0.24	0.3	0.99	0.9	0.77	0.91	0.99	0.74	0.83	-0.87		0.59	0.91
Property Plant And Equipment Gross	-0.78	0.75	0.57	0.63	0.64	0.62	0.34	0.83	-0.4	0.43	0.49	0.61	0.72	0.65	0.51	0.54	0.61	0.78	0.66	0.54	0.84	0.8	-0.87	0.59		0.74
Total Current Assets	-0.35	0.98	0.89	0.69	0.87	0.52	0.67	0.91	-0.06	0.68	0.67	0.97	0.91	0.4	0.56	0.86	0.97	0.79	0.9	0.86	0.86	0.92	-0.84	0.91	0.74

Click cells to compare fundamentals

Zoetis Account Relationship Matchups

Zoetis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.5B	13.6B	13.9B	14.9B	14.3B	10.5B
Short Long Term Debt Total	6.6B	7.4B	6.7B	8.1B	6.8B	5.1B
Other Current Liab	55M	1.1B	1.3B	1.3B	1.4B	770.2M
Total Current Liabilities	1.8B	2.2B	1.8B	3.2B	1.9B	1.7B
Total Stockholder Equity	2.7B	3.8B	4.5B	4.4B	5.0B	3.2B
Other Liab	917M	891M	811M	585M	672.8M	614.3M
Property Plant And Equipment Net	2.1B	2.4B	2.6B	3.0B	3.4B	2.0B
Current Deferred Revenue	950M	1.0B	6M	5M	4.5M	4.3M
Net Debt	4.7B	3.8B	3.3B	4.5B	4.7B	3.4B
Accounts Payable	301M	457M	436M	405M	411M	367.5M
Cash	1.9B	3.6B	3.5B	3.6B	2.0B	1.7B
Non Current Assets Total	6.8B	7.0B	7.0B	7.4B	7.9B	5.6B
Other Assets	160M	392M	211M	320M	368M	222.8M
Long Term Debt	5.9B	6.6B	6.6B	6.6B	6.6B	4.8B
Cash And Short Term Investments	1.9B	3.6B	3.5B	3.6B	2.0B	1.7B
Net Receivables	1.1B	1.0B	1.1B	1.2B	1.3B	1.1B
Good Will	2.6B	2.7B	2.7B	2.7B	2.8B	2.0B
Liabilities And Stockholders Equity	11.5B	13.6B	13.9B	14.9B	14.3B	10.5B
Non Current Liabilities Total	7.0B	7.7B	7.6B	7.4B	7.4B	5.6B
Inventory	1.4B	1.6B	1.9B	2.3B	2.6B	1.7B
Other Current Assets	318M	366M	389M	365M	434M	301.3M
Other Stockholder Equity	(998M)	(1.2B)	(1.9B)	(3.5B)	(4.5B)	(4.2B)
Total Liab	8.8B	9.8B	9.4B	10.5B	9.3B	7.3B
Property Plant And Equipment Gross	2.1B	2.2B	4.7B	5.3B	6.0B	6.3B
Total Current Assets	4.7B	6.6B	6.9B	7.5B	6.3B	4.9B
Accumulated Other Comprehensive Income	(726M)	(730M)	(764M)	(817M)	(839M)	(797.1M)
Short Term Debt	500M	604M	41M	1.4B	3M	2.9M
Intangible Assets	1.9B	1.7B	1.5B	1.4B	1.3B	1.4B
Property Plant Equipment	1.9B	2.2B	2.4B	2.8B	3.2B	1.8B
Retained Earnings	4.4B	5.7B	7.2B	8.7B	10.3B	10.8B
Retained Earnings Total Equity	4.4B	5.7B	7.2B	8.7B	10.0B	10.5B
Deferred Long Term Liab	434M	378M	320M	142M	163.3M	290.0M
Treasury Stock	(2.0B)	(2.2B)	(3.0B)	(4.5B)	(4.1B)	(3.9B)
Net Tangible Assets	(1.8B)	(635M)	387M	279M	320.9M	336.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Zoetis Stock Analysis

When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC